Application no. and date | 12857932.3 (espacenet) (Federated) (European Patent Register), 20121213 | Patent/reg. no. and date | DK/EP 2790710, 20200826 | Publication date | 20141022 | Priority no. and date | US 201161569805 P, 20111213, US 201261680721 P, 20120808 | EP pub. no. and date |
EP 2790710 20141022 | Effective date | | Applicant/owner | Amorphical Ltd., P.O. Box 15021
84210 Beer-Sheva, IL | Applicant ref. no. | P5813DKEP | Inventor | SHECHTER, Assaf, 16 Hapardes Street
64245 Tel Aviv, IL, SAGI, Amir, 68 Eshel Street
Omer 84965, IL, SHALTIEL-GOLD, Galit, 8 Harduf Street
84965 Omer, IL, MEIRON, Oren, 113/8 Bialik Street
84308 Beer Sheva, IL, DANIELY, Michal, 5 Harimon Street
55900 Ganey-Tiqwa, IL | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | Opponent | | IPC Class | A61K 31/663 (2006.01) , A61K 33/10 (2006.01) , A61K 35/612 (2015.01) , A61P 19/10 (2006.01) | Title | Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser | Int. application no. | IL2012050521 | Int. publication no. | WO2013088440 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|